ImmuCell Corporation
5.03
-0.15 (-2.90%)
At close: Jan 15, 2025, 10:55 AM

ImmuCell Corporation Revenue Breakdown

Quarter Dec 31, 2021Sep 30, 2021Jun 30, 2021
FirstDefenseProductLineMember Revenue 5.40M 5.03M 4.47M
FirstDefenseProductLineMember Revenue Growth +7.35% +12.53% n/a
OtherAnimalHealthMember Revenue 40.59K 116.75K 68.86K
OtherAnimalHealthMember Revenue Growth -65.23% +69.53% n/a

Revenue by Geography

Quarter Dec 31, 2021
Otherstatesmember Revenue 2.62M
Otherstatesmember Revenue Growth n/a
United States Revenue 16.62M
United States Revenue Growth n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 844.04M 1.59M 1.33M 1.20M 817.49K 1.25M 1.45M 1.58M 1.19M 1.19M 1.27M 1.33M 1.10M 858.71K 945.75K 1.08M 850.90K 887.88K 1.06M 1.11M 896.43K 976.00K 1.03M 1.06M 891.31K 918.43K 954.96K 891.00K 832.43K 799.65K 894.11K 845.60K 846.44K 837.96K 756.15K 864.93K 683.31K 644.83K 700.21K
Selling, General, and Administrative Revenue Growth +53098.65% +19.04% +11.54% +46.18% -34.54% -13.66% -8.26% +32.16% +0.46% -6.81% -3.86% +20.48% +28.11% -9.20% -12.83% +27.51% -4.16% -16.62% -3.90% +23.60% -8.15% -4.85% -3.14% +18.81% -2.95% -3.83% +7.18% +7.04% +4.10% -10.56% +5.74% -0.10% +1.01% +10.82% -12.58% +26.58% +5.97% -7.91% n/a
Research and Development Revenue 786.14M 1.03M 1.26M 1.07M 1.12M 1.10M 1.11M 1.05M 1.27M 1.14M 1.04M 1.09M 1.05M 1.00M 1.03M 1.17M 1.12M 1.09M 974.43K 972.00K 984.73K 820.00K 910.37K 1.26M 908.79K 761.89K 582.93K 734.00K 585.83K 387.01K 339.62K 253.74K 307.72K 380.43K 302.44K 331.14K 301.75K 271.76K 330.67K
Research and Development Revenue Growth +76186.70% -18.38% +18.44% -4.69% +1.72% -0.98% +5.80% -17.36% +11.52% +9.93% -4.99% +4.09% +4.74% -3.00% -11.87% +4.17% +3.36% +11.51% +0.25% -1.29% +20.09% -9.93% -27.92% +38.98% +19.28% +30.70% -20.58% +25.29% +51.38% +13.95% +33.85% -17.54% -19.11% +25.79% -8.67% +9.74% +11.03% -17.81% n/a
Sales and Marketing Revenue 844.04M 984.96K 800.92K 671.51K 817.49K 719.79K 879.43K 3.26M 1.19M 659.24K 811.50K 2.62M 656.42K 436.98K 520.60K 1.08M 459.12K 465.52K 582.90K 1.11M 497.65K 976.00K 607.10K 1.06M 494.70K 475.23K 531.90K 891.00K 446.73K 400.45K 514.48K 466.30K 483.71K 462.31K 419.00K 519.97K 381.74K 316.29K 388.90K
Sales and Marketing Revenue Growth +85593.59% +22.98% +19.27% -17.86% +13.57% -18.15% -72.99% +172.97% +80.97% -18.76% -68.98% +298.53% +50.22% -16.06% -52.02% +136.32% -1.38% -20.14% -47.39% +122.64% -49.01% +60.76% -42.67% +114.07% +4.10% -10.66% -40.30% +99.45% +11.56% -22.16% +10.33% -3.60% +4.63% +10.34% -19.42% +36.21% +20.69% -18.67% n/a